A possible link between sensation-seeking status and positive subjective effects of oxycodone in healthy volunteers

Pharmacology Biochemistry and Behavior

Volumn 95, Issue 1, 2010, Pages 113-120

  Zacny, James P ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Abuse liability; Human; Opioid; Oxycodone; Personality; Prescription opioid; Sensation seeking; Subjective

Indexed keywords

LORAZEPAM; MORPHINE; OPIATE; OXYCODONE; PARACETAMOL; PLACEBO;

ADULT; ARTICLE; COGNITION; DOSE RESPONSE; DRUG ABUSE; DRUG MECHANISM; DRUG RESPONSE; DRUG USE; DYSPHORIA; FEMALE; HAPPINESS; HUMAN; HUMAN EXPERIMENT; MALE; NAUSEA; NORMAL HUMAN; PERSONALITY; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; PSYCHOPHARMACOLOGY; RATING SCALE; RETROSPECTIVE STUDY; SEX DIFFERENCE;

ANALGESICS, OPIOID; FEMALE; HUMANS; MALE; OXYCODONE; REFERENCE VALUES; RETROSPECTIVE STUDIES;

EID: 77249139914     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2009.12.015     Document Type: Article

References (69)

1. Alterman A.I., Hall J.G., Purtill J.J., Searles J.S., Holahan J.M., McLellan A.T. Heavy drinking and its correlates in young men. Addict Behav 1990, 15:95-103.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR (text revision) 2000, American Psychiatric Association, Washington, DC.
3. Andrucci G.L., Archer R.P., Pancoast D.L., Gordon R.A. The relationship of MMPI and Sensation Seeking Scales to adolescent drug use. J Pers Assess 1989, 53:253-266.
4. Baddeley A.D. A three-minute reasoning test based on grammatical transformation. Psychon Sci 1968, 10:341-342.
5. Bardo M.T., Donohew R.L., Harrington N.G. Psychobiology of novelty seeking and drug seeking behavior. Behav Brain Res 1996, 77:23-24.
6. Beck K.H., Thombs D.L., Mahoney C.A., Fingar K.M. Social context and sensation seeking: gender differences in college student drinking motivations. Int J Addict 1995, 30:1101-1115.
7. Bevins R.A., Klebaur J.E., Bardo M.T. Individual differences in response to novelty, amphetamine-induced activity and drug discrimination in rats. Behav Pharmacol 1997, 8:113-123.
8. Birnbaum H.G., White A.G., Reynolds J.L., Greenberg P.E., Zhang M., Vallow S., et al. Estimated costs of prescription opioid analgesic abuse in the United States in 2001. Clin J Pain 2006, 22:667-676.
9. Bobes J., Saiz P.A., Gonzalez M.P., Bascaran M.T., Bousono M., Ricaurte G.A., et al. Use of MDMA and other illicit drugs by young adult males in northern Spain. A five-year study. Eur Addict Res 2002, 8:147-154.
10. Bradley C.M., Nicholson A.N. Studies on performance with aspirin and paracetamol and with the centrally acting analgesics meptazinol and pentazocine. Eur J Clin Pharmacol 1987, 32:135-139.
11. Cepeda M.S., Farra J.Y., Baumgarten M., Boston R., Carr D.B., Strom B.L. Side effects of opioids during short-term administration: effects of age, gender and race. Clin Pharmacol Ther 2003, 74:102-112.
12. Chait L.D. Reinforcing and subjective effects of methylphenidate in humans. Behav Pharmacol 1994, 5:281-288.
13. Cicero T.K., Inciardi J.A., Munoz A. Trends in abuse of OxyContin and other opioid analgesics in the United States: 2002-2004. J Pain 2005, 6:662-672.
14. Clapper R.L., Martin C.S., Clifford P.R. Personality, social environment, and past behavior as predictors of late adolescent drug use. J Subst Abuse 1994, 6:305-313.
15. Cloninger C.R. A systematic method for clinical description and classification of personality variants. Arch Gen Psychiatry 1987, 4:573-585.
16. Comer S.D., Sullivan M.A., Whittington R.A., Vosburg S.K., Kowalczyk W.J. Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers. Neuropsychopharmacology 2008, 33:1179-1191.
17. Dasgupta N., Kramer E.D., Zalman M.A., Carino S., Smith M.Y., Haddox J.D., et al. Association between non-medical and prescriptive usage of opioids. Drug Alcohol Depend 2006, 82:135-142.
18. de Wit H., Uhlenhuth E.H., Pierri J., Johanson C.E. Individual differences in behavioral and subjective responses to alcohol. Alcohol Clin Exp Res 1987, 11:52-59.
19. Deroche V., Piazza P.V., Le Moal M., Simon H. Individual differences in the psychomotor effects of morphine are predicted by reactivity to novelty and influenced by corticosterone secretion. Brain Res 1993, 623:341-344.
20. Eade N.R., Lasagna L. A comparison of acetophenetidin and acetaminophen. II. Subjective effects in healthy volunteers. J Pharmacol Exp Ther 1967, 155:301-308.
21. Erblich J., Earleywine M. Behavioral undercontrol and subjective stimulant and sedative effects of alcohol intoxication: independent predictors of drinking habits? Alcohol Clin Exp Res 2003, 27:44-50.
22. Evans S.M., Funderburk F.R., Griffiths R.R. Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability. J Pharmacol Exp Ther 1990, 255:1246-1255.
23. Evans S.M., Griffiths R.R., de Wit H. Preference for diazepam, but not buspirone, in moderate drinkers. Psychopharmacology 1996, 123:154-163.
24. Eysenck H.J., Eysenck S.B.G. Manual of the Eysenck Personality Inventory 1964, University of London, London.
25. Fillingim R.B., Ness T.J., Glover T.L., Campbell C.M., Hastie B.A., Price D.D., et al. Morphine responses and experimental pain: sex differences in side effects and cardiovascular responses but not analgesia. J Pain 2005, 6:116-124.
26. Fillmore M.T., Ostling E.W., Martin C.A., Kelly T.H. Acute effects of alcohol on inhibitory control and information processing in high and low sensation-seekers. Drug Alcohol Depend 2009, 100:91-99.
27. Franques P., Auriacombe M., Piquemal E., Verger M., Brisseau-Gimenez S., Grabot D., et al. Sensation seeking as a common factor in opioid dependent subjects and high risk sport practicing subjects. A cross sectional study. Drug Alcohol Depend 2003, 69:121-126.
28. Fraser H.F., van Horn G.D., Martin W.R., Wolbach A.B., Isbell H. Methods for evaluating addiction liability. (a) "attitude" of opiate addicts toward opiate-like drugs, (b) a short-term "direct" addiction test. J Pharmacol Exp Ther 1961, 133:371-387.
29. Gilson A.M., Ryan K.M., Joranson D.E., Dahl J.L. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002. J Pain Symptom Manage 2004, 28:176-188.
30. Goodstadt M.S., Cook G., Magid S., Gruson V. The Drug Attitude Scale (DAS): its development and evaluation. Int J Addict 1978, 13:1307-1317.
31. Haertzen C.A. Development of scales based on patterns of drug effects, using the Addiction Research Center Inventory (ARCI). Psychol Rep 1966, 18:163-194.
32. Hittner J.B., Swickert R. Sensation seeking and alcohol use: a meta-analytic review. Addict Behav 2006, 31:1383-1401.
33. Hooks M.S., Kalivas P.W. Involvement of dopamine and excitatory amino acid transmission in novelty-induced motor activity. J Pharmacol Exp Ther 1994, 269:976-988.
34. Hutchison K.E., Wood M.D., Swift R. Personality factors moderate subjective and psychophysiological responses to d-amphetamine in humans. Exp Clin Psychopharmacol 1999, 7:493-501.
35. Jaffe L.T., Archer R.P. The prediction of drug use among college students from MMPI, MCMI, and sensation seeking scales. J Pers Assess 1987, 51:243-253.
36. Kelly T.H., Robbins G., Martin C.A., Fillmore M.T., Lane S.D., Harrington H.G., et al. Individual differences in drug abuse vulnerability: d-amphetamine and sensation-seeking status. Psychopharmacology 2006, 189:17-25.
37. Kelly T.H., Delzer T., Martin C.A., Harrington N.G., Hays L.R., Bardo M.J. Performance and subjective effects of diazepam and d-amphetamine in high and low sensation seekers. Behav Pharmacol 2009, 20:505-517.
38. Liraud F., Verdoux H. Which temperamental characteristics are associated with substance use in subjects with psychotic and mood disorders? Psychiatry Res 2000, 93:63-72.
39. Martin W.R., Sloan J.W., Sapira J.D., Jasinski D.R. Physiologic, subjective and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 1971, 12:245-258.
40. Martin C.A., Kelly T.H., Rayens M.K., Brogli B.R., Brenzel A., Smith W.J., et al. Sensation seeking, puberty, and nicotine, alcohol, and marijuana use in adolescence. J Am Acad Child Adolesc Psychiatry 2002, 41:1495-1502.
41. McColl S., Sellers E.M. Research design strategies to evaluate the impact of formulations on abuse liability. Drug Alcohol Depend 2006, 83(Suppl 1):S52-S62.
42. Nuotto E.J., Korttila K. Evaluation of a new computerized psychomotor test battery: effects of alcohol. Pharmacol Toxicol 1991, 68:360-365.
43. Pedersen W., Clausen S.E., Lavik N.J. Patterns of drug use and sensation-seeking among adolescents in Norway. Acta Psychiatr Scand 1989, 79:386-390.
44. Perkins K.A., Gerlach D., Broge M., Grobe J.E., Wilson A. Greater sensitivity to subjective effects of nicotine in nonsmokers high in sensation seeking. Exp Clin Psychopharmacology 2000, 8:462-471.
45. Piazza P.V., Deminiere J.M., Le Moal M., Simon H. Factors that predict individual vulnerability to amphetamine self-administration. Science 1989, 245:1511-1513.
46. Piazza P.V., Deminiere J.M., Maccari S., Mormede P., Le Moal M., Simon H. Individual reactivity to novelty predicts probability of amphetamine self-administration. Behav Pharmacol 1990, 1:339-345.
47. Pickworth W.B., Klein S.A., George F.R., Henningfield J.E. Acetaminophen fails to inhibit ethanol-induced subjective effects in human volunteers. Pharmacol Biochem Behav 1991, 41:189-194.
48. Preston K.L., Bigelow G.E., Bickel W.K., Liebson I.A. Drug discrimination in human postaddicts: agonist-antagonist opioids. J Pharmacol Exp Ther 1989, 250:184-196.
49. Saigusa T., Tuinstra T., Koshikawa N., Cools A.R. High and low responders to novelty: effects of a catecholamine synthesis inhibitor on novelty-induced changes in behaviour and release of accumbal dopamine. Neuroscience 1999, 88:1153-1163.
50. Stephenson M.T., Hoyle R.H., Palmgreen P., Slater M.D. Brief measures of sensation seeking for screening and large-scale surveys. Drug Alcohol Depend 2003, 72:279-286.
51. Stoops W.W., Fillmore M.T., Poonacha M.S., Kingery J.E., Rush C.R. Alcohol choice and amphetamine effects in light and moderate drinkers. Alcohol Clin Exp Res 2003, 27:804-811.
52. Stoops W.W., Lile J.A., Robbins C.G., Martin C.A., Rush C.R., Kelly T.H. The reinforcing, subject-rated, performance, and cardiovascular effects of d-amphetamine: influence of sensation-seeking status. Addict Behav 2007, 32:1177-1188.
53. Substance Abuse and Mental Health Services Administration (SAMHSA), Office of Applied Studies, 2008. Results from the 2007 National Survey on Drug Use and Health: Detailed Tables, accessed November 6, 2009. http://www.oas.samhsa.gov/NSDUH/2k7NSDUH/tabs/Sect1peTabs88to92.pdf.
54. Teichman M., Barnea Z., Ravav G. Personality and substance use among adolescents: a longitudinal study. Br J Addict 1989, 84:181-190.
55. Wechsler D. The measurement and appraisal of adult intelligence 1958, Williams and Wilkins, Baltimore MD.
56. West M.M. Early risk indicators of substance abuse among nurses. J Nurs Scholarship 2002, 34:187-193.
57. Wright C.W., Kramer E.D., Zalman M.-A., Smith M.Y., Haddox J.D. Risk identification, risk assessment, and risk management of abusable drug formulations. Drug Alcohol Depend 2006, 83S:S68-S76.
58. Zacny J.P., de Wit H. The prescription opioid, oxycodone, does not alter behavioral measures of impulsivity in healthy volunteers. Pharmacol Biochem Behav 2009, 94:108-113.
59. Zacny J.P., Drum M. Psychopharmacological effects of oxycodone in healthy volunteers: roles of alcohol-drinking status and sex. Drug Alcohol Depend 2009, Nov 28, Electronic publication, ahead of print.
60. Zacny J.P., Gutierrez S. Characterizing the subjective, psychomotor, and physiological effects of oral oxycodone in non-drug-abusing volunteers. Psychopharmacology 2003, 170:242-254.
61. Zacny J.P., Gutierrez S. Within-subject comparison of the psychopharmacological profiles of oral hydrocodone and oxycodone combination products in non-drug-abusing volunteers. Drug Alcohol Depend 2009, 101:107-114.
62. Zacny J.P., Lichtor S. Within-subject comparison of the psychopharmacological profiles of oral oxycodone and oral morphine in non-drug-abusing volunteers. Psychopharmacology 2008, 196:105-116.
63. Zacny J., Bigelow G., Compton P., Foley K., Iguchi M., Sannerud C. College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement. Drug Alcohol Depend 2003, 69:215-232.
64. Zacny J.P., Gutierrez S., Bolbolan S.A. Profiling the subjective, psychomotor, and physiological effects of a hydrocodone/acetaminophen product in recreational drug users. Drug Alcohol Depend 2005, 78:243-252.
65. Zuckerman M. Sensation-Seeking: Beyond the Optimal Level of Arousal 1979, Erlbaum, Hillsdale NJ.
66. Zuckerman M. Behavioral expressions and biosocial bases of sensation seeking 1994, Cambridge University Press, New York.
67. Zuckerman M., Eysenck S., Eysenck H.J. Sensation seeking in England and America: cross-cultural, age, and sex comparisons. J Consult Clin Psychol 1978, 46:139-149.
68. Zuckerman M., Kuhlman D.M., Joireman J., Teta P., Kraft M. A comparison of three structural models for personality: the big three, the big five, and the alternative five. J Pers Soc Psychol 1993, 65:757-768.
69. Zun L.S., Downey L.V., Gossman W., Rosenbaumdagger J., Sussman G. Gender differences in narcotic-induced emesis in the ED. Am J Emerg Med 2002, 20:151-154.